News

glucose-metabolism-alzheimers-neurosciencenews-public
24 Feb 2017

For the first time a “tipping point” molecular link between the blood sugar glucose and Alzheimer’s disease has been established by scientists, who have shown that excess glucose damages a vital enzyme involved with inflammation response to the early stages of Alzheimer’s. Abnormally high blood sugar levels, or hyperglycaemia, is well-known as a characteristic of diabetes and obesity,...
Read More..

Anti-blood-clot-molecule-for-web
19 Feb 2017

A designer molecule developed by Monash University researchers opens the way for a powerful new treatment targeting life-threatening blood clots that cause heart attack or stroke – significantly reducing the risk of permanent brain damage or disability. The treatment also comes without the associated side effects of excessive bleeding. Heart attack and stroke are leading causes of death and...
Read More..

Nick Huntington
16 Feb 2017

A team of researchers from Australia and France have uncovered new insights into how to prolong the lifespan of the body’s disease-fighting natural killer (NK) cells. The finding offers fresh clues about how best to harness NK cells to improve their disease-fighting function. This may have particular importance for cancer immunotherapy, ‘buying more time’ for NK cells to detect and...
Read More..

Elephants picture
31 Jan 2017

The majestic pachyderms that are well-known for their extraordinary strength and memory are also quite good at avoiding cancer. Now, scientists studying this phenomenon say they’ve discovered an elephant protein that may destroy human cancer cells.   It’s an odd phenomenon that scientists have observed: elephants rarely get cancer despite their massive size, and, presumably, more cell...
Read More..

Image: On the left, many green-labeled neutrophils carrying the C5a receptor have moved out from the grey blood vessel into the joint of a mouse in which inflammatory arthritis has been induced. In an animal lacking expression of the C5a receptor on neutrophils (right), only a few adhere to the blood vessel wall and, after quickly detaching, do not enter the joint. Credit: Yoshishige Miyabe, MD, PhD, Massachusetts General Hospital Center for Immunology and Inflammatory Diseases
26 Jan 2017

New technology allows scientists to watch immune cells move in real time, and researchers recently took advantage of this capability to understand the molecular players involved during joint inflammation for individuals with inflammatory arthritis. Inflammatory arthritis, whether as a result of rheumatoid arthritis, lupus, or another autoimmune disease, often stems from a type III...
Read More..